
    
      The objects of this research are as follows:

      (1) To measure the duration of viral shedding in respiratory secretions of patients with
      moderate or severe COVID-19 infection treated with the combination of Hydroxychloroquine and
      azithromycin. (2) Evaluate the case fatality rate, the clinical response and length of stay
      in hospitalized patients with moderate and severe COVID-19 infection. (3) To report the
      safety of the drug combination in hospitalized patients with moderate and severe COVID-19
      infection.
    
  